Clinical Trials Directory

Trials / Conditions / Stage IIIC Uterine Corpus Cancer

Stage IIIC Uterine Corpus Cancer

8 registered clinical trials studyying Stage IIIC Uterine Corpus Cancer.

StatusTrialSponsorPhase
CompletedAcceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partn
NCT03112668
Rutgers, The State University of New JerseyN/A
CompletedCarevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors
NCT03198286
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityN/A
CompletedTrial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed
NCT02501954
Women's Cancer Care Associates, LLCPhase 3
CompletedPhysical Activity Behavioral Intervention in Obese Endometrial Cancer Survivors
NCT02575872
Albert Einstein College of MedicineN/A
CompletedVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
NCT01522820
Roswell Park Cancer InstitutePhase 1
CompletedTemsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Isl
NCT01010126
National Cancer Institute (NCI)Phase 2
TerminatedRadiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer
NCT01041027
Albert Einstein College of MedicinePhase 2
CompletedIntraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV En
NCT00575952
Gynecologic Oncology GroupPhase 1